Abelacimab [2098724-83-3]

TargetMol Chemicals

Abelacimab

9

2098724-83-3

Antibody

Research Use Only

Abelacimab

Abelacimab (MAA868), a fully human IgG1 monoclonal antibody, targets and binds with high affinity to FXIs catalytic structural domain. This interaction ensures FXI remains in its zymogen form, effectively inhibiting activation by FXIIa or thrombin. Such a mechanism underscores Abelacimabs potential application in thromboembolic disease research [1] [2].

3 years

-20°C

12352203